Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience

about

Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience

Item

http://www.wikidata.org/entity/Q42154228

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Unraveling the spectrum of KIT ...... tiary Cancer Center Experience

@en

Unraveling the spectrum of KIT ...... tiary Cancer Center Experience

@nl

type

Item

label

Unraveling the spectrum of KIT ...... tiary Cancer Center Experience

@en

Unraveling the spectrum of KIT ...... tiary Cancer Center Experience

@nl

prefLabel

Unraveling the spectrum of KIT ...... tiary Cancer Center Experience

@en

Unraveling the spectrum of KIT ...... tiary Cancer Center Experience

@nl

P1476

Unraveling the spectrum of KIT ...... tiary Cancer Center Experience

@en

P2093

Anant Ramaswamy

http://www.w3.org/2001/XMLSchema#string

Mamta Gurav

http://www.w3.org/2001/XMLSchema#string

Mukta Ramadwar

http://www.w3.org/2001/XMLSchema#string

Munita Bal

http://www.w3.org/2001/XMLSchema#string

Omshree Shetty

http://www.w3.org/2001/XMLSchema#string

Sangeeta Desai

http://www.w3.org/2001/XMLSchema#string

Trupti Pai

http://www.w3.org/2001/XMLSchema#string

Vikas Ostwal

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.

Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors.

DNA ploidy and c-Kit mutation in gastrointestinal stromal tumors

Pathology of gastrointestinal stromal tumors.

Molecular characterisation of gastrointestinal stromal tumours in a South African population

Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS)

Pazopanib in metastatic multiply treated progressive gastrointestinal stromal tumors: feasible and efficacious.

Gastrointestinal stromal tumors: what do we know now?

P304

113-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/SAJC.SAJC_275_16

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28975118

http://www.w3.org/2001/XMLSchema#string

P921

India

P932

5615879

http://www.w3.org/2001/XMLSchema#string